Department of Molecular and Medical Pharmacology

Parent: UCLA

eScholarship stats: History by Item for June through September, 2026

Item	Title	Total requests	2026-09	2026-08	2026-07	2026-06
3rh986fd	Macrophage COX2 Mediates Efferocytosis, Resolution Reprogramming, and Intestinal Epithelial Repair	1,227	245	464	218	300
19k5q59f	The pentose phosphate pathway in health and disease	675	142	332	79	122
47h17394	PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0	645	204	292	78	71
9292w8n6	Multiple early factors anticipate post-acute COVID-19 sequelae	614	273	250	41	50
54c114pc	Multivalent N‑Acetylgalactosamine-Conjugated siRNA Localizes in Hepatocytes and Elicits Robust RNAi-Mediated Gene Silencing	566	161	176	100	129
4xj2w70k	Chapter Five Advances in PET Detection of the Antitumor T Cell Response	551	136	146	119	150
4sk065dz	Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trial	536	62	106	123	245
1zv2z6bg	RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults	449	184	106	75	84
7jm3422h	PD-1 blockade induces responses by inhibiting adaptive immune resistance	437	103	130	94	110
5mp7824g	Immunoresponsive Gene 1 and Itaconate Inhibit Succinate Dehydrogenase to Modulate Intracellular Succinate Levels*	427	187	113	75	52
69s4b6hb	Osteopontin as a Biomarker in Chronic Kidney Disease	410	113	188	45	64
4z6394j3	Human T cell generation is restored in CD3δ severe combined immunodeficiency through adenine base editing	378	131	187	37	23
61s0k68s	Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma	365	114	94	67	90
5nv9f110	Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression	348	72	88	85	103
0290023m	B7-H3-liquid biopsy for the characterization and monitoring of the dynamic biology of prostate cancer	347	49	64	114	120
9br8v18z	Radiation Dosimetry and Biodistribution of 68Ga-FAPI-46 PET Imaging in Cancer Patients	347	104	119	56	68
9623t7mm	Genome-wide association meta-analysis in 269,867 individuals identifies new genetic and functional links to intelligence	343	82	74	72	115
7tf918cz	Effect of Exercise Training on Striatal Dopamine D2/D3 Receptors in Methamphetamine Users during Behavioral Treatment	334	120	93	22	99
0cj1q8m0	Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations	328	84	93	44	107
87s8b0ff	Isolation of Mitochondria from Mouse Tissues for Functional Analysis	323	69	104	54	96
46k649vw	Mitochondria Bound to Lipid Droplets Have Unique Bioenergetics, Composition, and Dynamics that Support Lipid Droplet Expansion	322	82	77	52	111
87x612c2	Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma	315	88	95	63	69
837669fc	Individual islet respirometry reveals functional diversity within the islet population of mice and human donors	314	42	57	69	146
5xq2c221	Metabolic programs of T cell tissue residency empower tumour immunity	308	71	85	67	85
342329sk	Context-dependent regulation of ferroptosis sensitivity	299	96	79	70	54
8094s6nw	Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction	297	82	109	48	58
2r15x44h	Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT)	294	62	157	44	31
7w98t225	Etomoxir Inhibits Macrophage Polarization by Disrupting CoA Homeostasis	293	72	128	31	62
0cj235rr	Epigenetic Induction of Cancer-Testis Antigens and Endogenous Retroviruses at Single-Cell Level Enhances Immune Recognition and Response in Glioma	292	101	63	51	77
1n83k1hm	The “cancer immunogram”	280	58	91	73	58
4zw2v599	CXCL9/10-engineered dendritic cells promote T cell activation and enhance immune checkpoint blockade for lung cancer	277	54	90	49	84
10s8335f	Gynecologic tumor board: a radiologist’s guide to vulvar and vaginal malignancies	276	43	95	69	69
7k76k99h	Objective response rate targets for recurrent glioblastoma clinical trials based on the historic association between objective response rate and median overall survival	276	57	112	33	74
2vz9776k	Identification of a novel mitochondrial uncoupler that does not depolarize the plasma membrane	273	69	113	31	60
11t728g9	Fibroblast Activation Protein Expression in Sarcomas	270	55	143	26	46
7f9896fs	Dosimetry of [177Lu]Lu-PSMA–Targeted Radiopharmaceutical Therapies in Patients with Prostate Cancer: A Comparative Systematic Review and Metaanalysis	270	72	105	36	57
5t6860dh	The mitochondrial fission protein Drp1 in liver is required to mitigate NASH and prevents the activation of the mitochondrial ISR	268	78	134	14	42
1387q04m	Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma	266	88	97	21	60
5gr4m7rp	Mammary duct luminal epithelium controls adipocyte thermogenic programme	265	44	46	65	110
0bh4n1vq	Targeted agents and immunotherapies: optimizing outcomes in melanoma	263	35	98	68	62
1cx8v95f	Hepatic nonvesicular cholesterol transport is critical for systemic lipid homeostasis	260	118	50	28	64
0g72g9bm	Neoadjuvant anti-PD1 immunotherapy for surgically accessible recurrent glioblastoma: clinical and molecular outcomes of a stage 2 single-arm expansion cohort.	259	69	62	46	82
65v3g86k	A Meta-analysis of Gene Expression Signatures of Blood Pressure and Hypertension	257	133	64	12	48
0f01h1g6	TCR Sequencing Can Identify and Track Glioma-Infiltrating T Cells after DC Vaccination	250	57	59	50	84
85j2d85f	Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma	246	59	85	48	54
5st231s3	Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy	243	58	72	50	63
9t809202	Mitochondrial morphology controls fatty acid utilization by changing CPT1 sensitivity to malonyl‐CoA	242	60	49	28	105
7s9850mt	N-Myristoytransferase Inhibition Causes Mitochondrial Iron Overload and Parthanatos in TIM17A-Dependent Aggressive Lung Carcinoma	237	62	58	80	37
2g96s8v7	Non-viral precision T cell receptor replacement for personalized cell therapy	236	62	48	39	87
2t45m6gj	Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study.	235	71	80	43	41

Top

Note: Due to the evolving nature of web traffic, the data presented here should be considered approximate and subject to revision. Learn more.